
AstraZeneca
AZNCF | OTC
$189.90
-$2.60 (-1.35%)
At close: Mar 13, 2026, 9:30 AM ET
Market Data
Market Cap $294.4B
Enterprise Value $320.13B
Beta 0.19
Average Volume N/A
Shares Outstanding (Diluted) 1.56B
Shares Change YoY -0.06%
Institutional Ownership N/A
Exchange N/A
ISIN N/A
Price Performance
Price Change 1M N/A
Price Change 3M N/A
Price Change 6M N/A
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -0.7%
1Y CAGR (ann.) 40.0%
5Y CAGR (ann.) 17.6%
All-Time CAGR 10.7%
Valuation
PE Ratio 35.76
Forward PE 16.29
PEG Ratio 1.07
Forward PEG 2.09
PS Ratio 5.21
Forward PS 4.40
PB Ratio 6.58
P/FCF Ratio 33.17
P/Adj. FCF Ratio 33.17
P/OCF Ratio 21.43
EV/Sales 5.67
EV/EBIT 27.37
EV/EBITDA 17.28
EV/FCF 36.06
Earnings Yield 2.8%
FCF Yield 3.0%
Adj. FCF Yield 3.0%
Financial Health
Net Debt $24.1B
Total Debt $32.84B
Cash & Short-Term Investments $7.11B
Total Assets $112.42B
Current Ratio 0.89
Quick Ratio 0.67
Debt / Equity Ratio 0.64
Debt / EBITDA 1.77
Debt / FCF 3.70
OCF / Debt 0.41
Interest Coverage 7.97
Altman Z-Score 3.51
Piotroski F-Score 8
Margins & Profitability
Gross Profit Margin 79.3%
Operating Profit Margin 20.0%
EBITDA Margin 33.4%
Net Profit Margin 17.0%
FCF Margin 15.7%
Adj. FCF Margin 15.7%
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets 9.0%
Return on Equity 21.7%
Return on Invested Capital 12.7%
Return on Capital Employed 16.4%
Return on Tangible Assets 18.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 8.7%
Revenue CAGR 5Y 17.1%
Revenue CAGR 10Y 8.2%
EPS CAGR 3Y 14.6%
EPS CAGR 5Y 26.5%
EPS CAGR 10Y 18.9%
FCF CAGR 3Y 18.5%
FCF CAGR 5Y 41.3%
FCF CAGR 10Y 15.0%
Analyst Forecasts
Analyst Rating N/A
Analyst Count N/A
EPS Growth Next 3Y 39.5%
Revenue Growth Next 3Y 10.0%
Earnings Date Nov 5, 2025
EPS Estimate (next Q) $2.29
EPS Growth Est (next Q) 10.1%
Revenue Est (next Q) $14.78B
Revenue Growth Est (next Q) 8.9%
Fair Value Estimates
Graham Number $62.45
Graham Upside -67.1%
Lynch Fair Value $132.75
Lynch Upside -30.1%
Price Target N/A
Price Target Upside N/A
Cash Flow
Operating Cash Flow $13.55B
Free Cash Flow $8.88B
Adj. Free Cash Flow $8.88B
FCF Per Share $5.44
OCF Per Share $8.86
OCF/S Ratio 22.4%
Income Statement
Revenue $56.5B
Gross Profit $45.98B
Operating Income $11.32B
EBITDA $18.52B
Net Income $8.37B
EPS (Diluted) $5.31
Revenue / Employee N/A
Profit / Employee N/A
Employees N/A
Dividends
Annual Dividend $3.23
Dividend Yield 1.70%
Payout Ratio 60.8%
FCF Payout Ratio 56.6%
Adj. FCF Payout Ratio 56.6%
Dividend Growth (YoY) 22.8%
Pay Frequency Semi-Annual
Ex-Dividend Date Aug 6, 2026
Add to Watchlist
Select watchlists to add or remove AZNCF